Patents by Inventor Michael E. Hogan

Michael E. Hogan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230349003
    Abstract: Provided herein are methods for identifying and serotyping Salmonella spp. serovars. Primer pairs and nucleic acid probes complementary to signature determinants in specific serovars are utilized for PCR amplification and hybridization for differentiation among specific Salmonella spp. serovars in a single sample.
    Type: Application
    Filed: March 30, 2023
    Publication date: November 2, 2023
    Applicant: PathogenDx, Inc.
    Inventors: Michael E. Hogan, Shaun Stice, Melissa May, Frederick Eggers
  • Publication number: 20220403476
    Abstract: Provided herein is a method for detecting the presence of a COVID-19 virus RNA or other pathogenic respiratory viruses, such as an influenza virus, or other RNA of interest in a sample. Nucleic acids are obtained from the sample and are used as a template in a combined isothermal reverse transcription, RNAse H and isothermal amplification reaction to generate single stranded RNA amplicons containing sequences complementary to fluorescent labeled detector probes. The single-stranded RNA amplicons hybridize to the detector probe and to hybridization probes with sequences complementary to a sequence determinant in the COVID-19 or other virus RNAs. The microarray is imaged to detect fluorescent signals thereby identifying the virus.
    Type: Application
    Filed: June 15, 2022
    Publication date: December 22, 2022
    Applicant: PathogenDx, Inc.
    Inventors: Fushi Wen, Frederick H. Eggers, Michael E. Hogan
  • Publication number: 20220298547
    Abstract: Provided herein are methods for isolating, detecting and analyzing a virus in a sample. Generally, the virus is isolated via centrifuging, incubating, aggregating, and lysing the sample to obtain a crude neutralized lysate. The crude neutralized lysate is analyzed and the virus(es) are detected by performing one of a first polymerase chain reaction (PCR) amplification followed by a second PCR amplification, by an isothermal amplification or by the reverse transcription reaction and the first polymerase chain reaction amplification together utilizing fluorescently labeled primer pairs and hybridizing the resultant fluorescent labeled amplicons to complementary nucleic acid probes.
    Type: Application
    Filed: March 18, 2022
    Publication date: September 22, 2022
    Applicant: PathogenDx, Inc.
    Inventor: Michael E. Hogan
  • Publication number: 20220136036
    Abstract: The invention relates to methods of treating diseases comprising administering to a subject a composition comprising the recombinant adeno-associated virus (rAAV). The rAAV is produced by a method comprising: obtaining a template DNA sequence containing a [ITR-cargo-ITR] DNA sequence motif; designing a PCR primer pair such that the 3? terminus of both the forward and reverse PCR primers overlap only about the last 2-8 bases of the A/A? ITR sequences and the 5? terminus of both the forward and reverse PCR primers extend into about 20-35 bases of the flanking sequences; performing PCR with cycling parameters comprising a combined annealing/extension step at a temperature greater than 70° C., thereby producing a plurality of amplicon polynucleotides containing the desired [ITR-cargo-ITR] DNA sequence motif; transfecting the amplicon polynucleotides containing the desired [ITR-cargo-ITR] DNA sequence motif into a packaging cell line; and purifying the lysed cells to collect a quantity of rAAV.
    Type: Application
    Filed: January 18, 2022
    Publication date: May 5, 2022
    Applicant: APDN (B.V.I) Inc.
    Inventors: Michael E. HOGAN, Stephen HUGHES, Yuhua SUN
  • Publication number: 20220126258
    Abstract: A composition for measuring binding to HLA proteins has a substrate having a surface and a first array of HLA protein spots indirectly attached to the surface of the substrate. Each HLA protein within each spot is entrapped within a matrix that retains the native three-dimensional structure of the HLA protein while the HLA protein is indirectly attached to the surface. Also disclosed is a formulation to link protein to a solid support that has one or more proteins, a matrix, and one or more non-volatile water-soluble protein solvents, solutes, or combination thereof in an aqueous solution. The matrix is a cross-linked Oligo-dT network, a cross-linked Oligo-U network, a protein network having at least one protein, or a combination thereof.
    Type: Application
    Filed: December 30, 2021
    Publication date: April 28, 2022
    Inventor: Michael E. Hogan
  • Patent number: 11260363
    Abstract: The present invention provides a formulation to link protein to a solid support that comprises one or more proteins, Oligo-dT and one or more non-volatile, water-soluble protein solvents, solutes or combination thereof in an aqueous solution. Further provided is a method of attaching a protein to a surface of a substrate. The formulations provided herein are contacted onto the substrate surface, printed thereon and air dried. The substrate surface is irradiated with UV light to induce thymidine photochemical crosslinking via the thymidine moieties of the Oligo-dT.
    Type: Grant
    Filed: January 13, 2020
    Date of Patent: March 1, 2022
    Assignee: PURE TRANSPLANT SOLUTIONS L.L.C.
    Inventor: Michael E. Hogan
  • Patent number: 11214928
    Abstract: Methods for marking cellulosic products, including cellulosic fibers such as lyocell and cellulosic films, including methods for marking such products with a detectable nucleic acid marker to identify and validate the origin or authenticity of the products or items manufactured using such products. Detectably-marked cellulosic products marked with nucleic acid markers for authentication, validation and tracking are also provided.
    Type: Grant
    Filed: December 17, 2019
    Date of Patent: January 4, 2022
    Assignee: Applied DNA Sciences, Inc.
    Inventors: Lawrence Jung, Michael E. Hogan, Ming Hwa Benjamin Liang
  • Publication number: 20210353676
    Abstract: The present inventions provides systems and methods to manufacture genetically modified lymphocyte cells via the use of linear DNA expression amplicons, and uses of such genetically modified lymphocyte cells to treat disease. The present invention also provides for the composition of genetically modified lymphocyte cells.
    Type: Application
    Filed: July 12, 2021
    Publication date: November 18, 2021
    Inventors: Stephen Hughes, James A. Hayward, Michael E. Hogan
  • Publication number: 20210317540
    Abstract: Provided herein is a method of quantitating a fungus in a plant, plant product or agricultural product. Total nucleic acids are isolated from a sample of the plant or plant product, and an asymmetric PCR amplification reaction is performed using fluorescent labeled primer pairs to obtain fluorescent labeled fungal amplicons. These amplicons are hybridized to fungus specific nucleic acid probes that are attached on a microarray support. The microarray is imaged to detect fluorescent signals from the fluorescent labeled fungal amplicons. The fluorescent signal intensity is correlated to the quantity of fungus.
    Type: Application
    Filed: June 23, 2021
    Publication date: October 14, 2021
    Applicant: PathogenDx, Inc.
    Inventors: Melissa May, Frederick H. Eggers, Kevin M. O'Brien, Peaches R. Ulrich, Benjamin A. Katchman, Shayla Freeman, Michael E. Hogan
  • Publication number: 20210317528
    Abstract: Complex blood group typing can be performed at the DNA level, using for example, air-dried cheek swabs or finger prick blood in a microarray test that completely bypasses the need for DNA extraction prior to analysis of the blood group type.
    Type: Application
    Filed: July 23, 2019
    Publication date: October 14, 2021
    Applicant: GENOMICS USA, INC.
    Inventors: FREDERICK H. EGGERS, GEORGINA LOPEZ PADILLA, PO LIN, KEVIN O'BRIEN, MICHAEL E. HOGAN, KRISHNA JAYARAMAN
  • Publication number: 20210254078
    Abstract: Provided herein are non-plasmid derived DNA vaccines comprised solely of enzymatically produced amplicon expression vectors and their method of use to elicit antigen-specific immune responses in a subject. The enzymatically produced amplicon expression vectors may be specifically utilized as a DNA based cancer vaccine to express desired antigens or other immunogenic polypeptides within a subject to induce a specific anti-cancer antigen-specific immune response. The enzymatically produced amplicon expression vectors may also be utilized to express cancer-specific neoantigens.
    Type: Application
    Filed: April 27, 2021
    Publication date: August 19, 2021
    Inventors: Michael E. Hogan, Stephen Hughes, Antonella Conforti, Luigi Aurisicchio, Fabio Palombo
  • Publication number: 20210164046
    Abstract: A composition comprising micron or submicron particles covered by a monolayer of nucleic acid wherein the nucleic acid may be recovered from the submicron particles is claimed. Methods of attaching a nucleic acid to an object for authentication and methods of authenticating an object are also claimed.
    Type: Application
    Filed: February 15, 2021
    Publication date: June 3, 2021
    Inventors: Michael E. HOGAN, Lawrence JUNG, Yuhua SUN, Maciej Szczepanik
  • Publication number: 20210130898
    Abstract: Provided herein is a method for identifying a mastitis-causing microbe in a subject. A milk sample is centrifuged to form a microbial pellet, total nucleic acids are extracted from the pellet and a microarray analysis of extracted DNA from which the mastitis-causing microbe is identified from DNA hybridization to mastitis-causing microbe species-specific gene probes. Also provided is a method for diagnosing a bovine mastitis infection in a dairy cow after identifying the bovine mastitis-causing microbe in a raw milk sample from the dairy cow.
    Type: Application
    Filed: November 2, 2020
    Publication date: May 6, 2021
    Applicant: PathogenDx, Inc.
    Inventors: Michael E. Hogan, Frederick H. Eggers, Melissa R. May
  • Publication number: 20210054384
    Abstract: The present invention relates to systems and methods to produce recombinant adeno-associated virus (rAAV) utilizing one or more DNA constructs manufactured via polymerase chain reaction (PCR).
    Type: Application
    Filed: August 7, 2020
    Publication date: February 25, 2021
    Inventors: Michael E. HOGAN, Stephen Hughes, Yuhua Sun
  • Patent number: 10920274
    Abstract: A composition comprising submicron particles covered by a monolayer of nucleic acid wherein the nucleic acid may be recovered from the submicron particles is claimed. Methods of attaching a nucleic acid to an object for authentication and methods of authenticating an object are also claimed.
    Type: Grant
    Filed: February 7, 2018
    Date of Patent: February 16, 2021
    Assignee: APDN (B.V.I.) Inc.
    Inventors: Michael E. Hogan, Lawrence Jung, Nicole Richter, Yuhua Sun, Maciej Szczepanik
  • Patent number: 10888830
    Abstract: Provided herein are biomolecular hybridization devices comprising a substrate with a permanently and covalently attached surface of functional groups and an adsorbed monolayer of unmodified, single-stranded oligonucleotides all of which are 10 to about 24 bases in length as a saturated film of constrained oligonucleotides on the surface via direct non-covalent phosphate-surface adsorptive contact of substantially all phosphate groups of each oligonucleotide. The constrained oligonucleotides are effective to dissociably hybridize to a complementary single-stranded nucleic acid with asymmetric, non-helical base pairing and without oligonucleotide dissociation from the surface of the device. Also, provided are methods for hybridizing solution-state target nucleic acids to probe nucleic acids and for identifying a nucleotide sequence to which a nucleotide-binding protein binds using the biomolecular hybridization devices.
    Type: Grant
    Filed: March 20, 2018
    Date of Patent: January 12, 2021
    Assignees: Genomics USA, Inc., Baylor College of Medicine
    Inventors: Michael E. Hogan, Joseph G. Utermohlen, Frederick H. Eggers, Krishna Jayaraman
  • Publication number: 20200385824
    Abstract: The present invention relates generally to a system and method of tracking leather raw materials through the supply chain to create a source verifiable finished leather product through one or more applications of DNA taggants during the leather manufacturing process and the subsequent authentication of said DNA taggants.
    Type: Application
    Filed: June 10, 2020
    Publication date: December 10, 2020
    Inventors: Michael E. Hogan, Joanna Greenwood
  • Publication number: 20200224206
    Abstract: Provided herein are non-plasmid derived DNA vaccines comprised solely of enzymatically produced amplicon expression vectors and their method of use to elicit antigen-specific immune responses in a subject. The enzymatically produced amplicon expression vectors may be specifically utilized as a DNA based cancer vaccine to express desired antigens or other immunogenic polypeptides within a subject to induce a specific anti-cancer antigen-specific immune response. The enzymatically produced amplicon expression vectors may also be utilized to express cancer-specific neoantigens.
    Type: Application
    Filed: December 5, 2019
    Publication date: July 16, 2020
    Inventors: Michael E. Hogan, Stephen Hughes, Antonella Conforti, Luigi Aurisicchio, Fabio Palombo
  • Publication number: 20200199820
    Abstract: Methods for marking cellulosic products, including cellulosic fibers such as lyocell and cellulosic films, including methods for marking such products with a detectable nucleic acid marker to identify and validate the origin or authenticity of the products or items manufactured using such products. Detectably-marked cellulosic products marked with nucleic acid markers for authentication, validation and tracking are also provided.
    Type: Application
    Filed: December 17, 2019
    Publication date: June 25, 2020
    Inventors: Lawrence Jung, Michael E. Hogan, Ming Hwa Benjamin Liang
  • Publication number: 20200147580
    Abstract: The present invention provides a formulation to link protein to a solid support that comprises one or more proteins, Oligo-dT and one or more non-volatile, water-soluble protein solvents, solutes or combination thereof in an aqueous solution. Further provided is a method of attaching a protein to a surface of a substrate. The formulations provided herein are contacted onto the substrate surface, printed thereon and air dried. The substrate surface is irradiated with UV light to induce thymidine photochemical crosslinking via the thymidine moieties of the Oligo-dT.
    Type: Application
    Filed: January 13, 2020
    Publication date: May 14, 2020
    Inventor: Michael E. Hogan